GlassScriptPhysician profile
Andrew C Cupino
NPI 1922275023
$659.74
in general payments reported to CMS, 2019-2025
20 companies · $60.59 in 2025
The $60.59 reported for 2025 was less than what a typical Therapeutic Radiology provider received nationally (typical 2025 total: $179).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $113 · 2021: $55.80 · 2023: $59.68 · 2024: $72.70 · 2025: $60.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $138.32 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $68.45 | 2019-2020 | |
| Novocure INC. | $60.64 | 2021-2025 | Optune Lua (Novottf-200t), Optune |
| Ge Healthcare | $57.27 | 2024 | |
| Eusa Pharma (US) LLC | $41.90 | 2020-2021 | |
| Siemens Medical Solutions USA, INC. | $37.83 | 2023-2024 | Truebeam |
| Celgene Corporation | $34.74 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $34.26 | 2019-2020 | |
| Teleflex LLC | $21.42 | 2025 | Barrigel |
| Foundation Medicine, INC. | $20.51 | 2023 | |
| Boston Scientific Corporation | $17.37 | 2025 | Spaceoar Vue System - 10ml |
| Janssen Pharmaceuticals, INC | $17.08 | 2019 | |
| Amgen INC. | $16.77 | 2020 | |
| Abbvie INC. | $14.69 | 2019 | |
| Incyte Corporation | $14.50 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $14.16 | 2021 | |
| Taiho Oncology, INC. | $14.06 | 2019 | |
| Exelixis INC. | $13.40 | 2019 | |
| Seagen INC. | $11.39 | 2019 | |
| Array Biopharma INC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Cupino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.